5 - CKD Management of Complications

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/100

encourage image

There's no tags or description

Looks like no tags are added yet.

101 Terms

1
New cards

What is the pathophysiology of anemia of CKD?

kidneys secrete 90% of erythropoietin (EPO)

  • ↓ EPO → inadequate production of oxygen-carrying RBCs

  • results in: decreased erythrocyte half-life, iron deficiency, blood loss


2
New cards

What is the risk of anemia of CKD?

↑ morbidity & mortality from CV complications

3
New cards

What are the consequences of anemia of CKD?

  • fatigue

  • depression

  • reduced exercise tolerance

  • dyspnea

  • CV consequences (left ventricular hypertrophy, left ventricular systolic dysfunction)


4
New cards

What are symptoms of anemia in CKD?

  • fatigue/weakness/dizziness

  • headache, sob

  • mental confusion

  • cold intolerance, cold hands & feet

  • tingling in extremities

  • chest pain

  • pale skin

  • irregular heart beat


5
New cards

What are the diagnostic criteria of anemia?

  • men: hemoglobin <13 g/dL

  • women: hemoglobin <12 g/dL


6
New cards

What are the screening protocols of anemia?

evaluate levels in all CKD patients

  • anemia prevalence increases at stage G3

  • CBC, absolute reticulocyte count, serum ferritin, serum transferrin saturation, B12, folate


7
New cards

What are reasons for iron deficiency?

  • increased requirement for RBC production with ESA therapy

  • blood loss from bleeding or hemodialysis


8
New cards

How is iron status evaluated?

  • TSAT assesses available iron (serum iron/TIBC*100)

  • ferritin measures stored iron


9
New cards

What ferritin & TSAT levels indicate iron deficiency anemia in pts receiving hemodialysis?

  • ferritin ≦500ng/ml

  • TSAT ≦30%


10
New cards

What ferritin & TSAT levels indicate iron deficiency anemia in pts not receiving hemodialysis?

  • ferritin <100ng/ml + TSAT <40% OR

  • ferritin <300ng/ml + TSAT <25%


11
New cards

What is the treatment for iron deficiency anemia?

either IV iron (HD) or 1-3 months or oral iron (non-HD)

12
New cards

What are the guideline treatment targets for iron therapy?

reasonable to withhold routine iron if:

  • ferritin >700ng/ml

  • TSAT ≧40%


13
New cards

What are the treatment goals of anemia in CKD?

  1. increase oxygen-carrying capacity

  2. improve QOL

  3. decrease the need for blood transfusion


14
New cards

What is the dosing of oral iron?

200mg of elemental iron daily

15
New cards

What are the pros of oral iron?

  • inexpensive

  • readily available

  • doesn’t require IV access


16
New cards

What are the cons of oral iron?

  • GI side effects (dyspepsia, constipation)

  • compliance


17
New cards

What is the dosing of IV iron?

initial dose of 1000mg

18
New cards

When is IV dosing preferred to oral?

  • HD pts

  • pt does not respond to/tolerate oral


19
New cards

What are the pros of IV iron?

avoids concerns about adherence

20
New cards

What are the cons of IV iron?

  • requires IV access

  • severe infusion related reactions (rarely)


21
New cards

What is the recommendation for the initial admin of IV iron dextran?

  • monitor pt for 60mins after infusion

  • availability of resuscitative facilities included trained personnel


22
New cards

What is the recommendation for the initial admin of IV non-dextran iron?

  • suggested to monitor patients after infusion

  • availability of resuscitative facilities included trained personnel


23
New cards

What are nonspecific ADRs of IV iron therapy & what should be done if they occur?

  • chest tightness

  • dizziness

  • lightheadedness

  • nausea

  • itching

  • asymptomatic hypotension


STOP infusion

  • observe 15 mins

  • restart if well at 25%-50% rate


24
New cards

What are mild ADRs of IV iron therapy & what should be done if they occur?

nonspecific reaction PLUS minor urticaria


STOP infusion

  • observe

  • retrial after steroid or oral H1 blocker

  • restart if well at 25%-50% rate


25
New cards

What are moderate ADRs of IV iron therapy & what should be done if they occur?

  • severe chest pain

  • cough

  • tachycardia

  • hypotension

  • severe generalized urticaria


STOP infusion

  • give IV fluids

  • IV steroid 100mg hydrocortisone

  • H1 blocker

  • restart if well at 25%-50% rate


consider alt. iron preparation

26
New cards

What are severe ADRs of IV iron therapy & what should be done if they occur?

sudden onset of:

  • wheezing

  • stridor

  • cyanosis

  • hypotension

  • tachycardia


STOP infusion

  • give IV fluids

  • 15L oxygen

  • 0.5mg 1:1000 IM adrenaline

  • corticosteroid IV

  • β₂-adrenoreceptor agonist bronchodilator w/ nebulizer

  • AVOID future use


27
New cards

Which iron agent shows a slower increase in Hb, ferritin, or TSAT?

oral iron

28
New cards

What is the difference in ADRs of oral vs. IV iron?

  • oral: more frequent, less severe

  • IV: less frequent, more severe


29
New cards

Which iron agent is more expensive?

IV iron

30
New cards

Why may oral iron be more appealing than IV?

  • people who want to limit hospital visits

  • mobility inequality

  • preserves veins for HD vascular access


31
New cards

Which iron agent may show increased assured administration?

IV iron

32
New cards

Which iron agent should be avoided if intestinal absorption is impaired?

oral iron

33
New cards

What is the MOA of erythropoiesis-stimulating agents (ESA)?

  • glycoproteins manufactured by recombinant DNA tech

  • same biological activity as EPO → stimulates erythropoiesis


34
New cards

What must occur before ESA therapy is initiated?

correction of iron deficiency

35
New cards

Which agents are ESAs?

  • epoetin alfa (epogen, procrit)

  • epoetin-alfa-epbx (retacrit)

  • darbepoetin alfa (anaesp)

  • methoxy PEG-epoetin beta (mircera)


36
New cards

Which ESA agents are dosed three times weekly?

  • epoetin alfa

  • epoetin-alfa-epbx


37
New cards

Which ESA agent is dosed once weekly or every 2 weeks?

darbepoetin alfa

38
New cards

Which ESA agent is dosed every 2 weeks or monthly?

methoxy PEG-epoetin beta

39
New cards

At what Hgb levels may ESA be started in non-HD pts?

<10g/dL

40
New cards

At what Hgb levels should ESA be started in HD pts?

<10g/dL

41
New cards

What is initial dosing of epoetin alfa?

IV or SQ 50-100 units/kg/week divided into 3 weekly doses

42
New cards

What is initial dosing of darbepoetin?

IV or SQ 0.45 mcg/kg once weekly OR 0.75 mcg/kg every 2 weeks

43
New cards

What is the route of admin of ESA on HD or hemofiltration?

IV or SQ

44
New cards

What is the route of admin of ESA on peritoneal dialysis or not on hemodialysis?

SQ

45
New cards

When are ESA & IV iron generally used in combination?

stage 5 CKD on HD

46
New cards

When should ESA agents be evaluated for titration?

in 2-4 weeks

47
New cards

What should be done if Hgb changes by <1g/dL @ week 4?

dose should be increased 25%

48
New cards

What should be done if Hgb changes by >1g/dL @ week 2?

dose should be decreased 25%

49
New cards

What is the Hgb treatment target on ESAs?

<11.5g/dL

50
New cards

What are ESA ADRs?

  • hypertension

  • headache

  • flu-like


51
New cards

What are signs of ESA hypo-responsiveness?

  • iron deficiency

  • hyperparathyroidism

  • folate or vitamin B12 deficiency

  • malignancies

  • malnutrition


52
New cards

What should be monitored in anemia in CKD?

  • once stable, Hgb at least monthly

  • iron status at least every 3 months while on ESA therapy


53
New cards

What is the pathophysiology of mineral & bone disorders in CKD?

kidney function decline → ↓ phosphorus elimination → ↓ serum calcium concentration → ↑ PTH secretion

  • PTH ↓ phosphorous and ↑ calcium reabsorption in kidneys, mobilizing calcium from bone

  • also decreased conversion of dietary vitamin D → calcitriol, ↓ intestinal calcium absorption


54
New cards

What is the result of hyperphosphatemia?

  • ↑ PTH → bone breakdown → renal osetodystrophy

  • ↑CaPO4 product → precipitation in arteries, joints, soft tissues, & the viscera


55
New cards

Which level should be managed first (phosphorus/calcium/PTH)?

phosphorus

56
New cards

What is the target level of phosphorus?

2.5-4.5 mg/dL

57
New cards

What is the target level of calcium?

8.5-10.5 mg/dL

58
New cards

What is the target level of PTH?

2-9x ULN (120-540 pg/mL)

  • normal range 10-65 ng/L


59
New cards

What is the non-pharmacologic therapy for hyperphosphatemia in CKD?

  • dietary phosphorous restrictions in stage 3 or higher (800-1000mg/day)

  • dialysis removes various amounts of phosphorous (insufficient to maintain appropriate level)


60
New cards

What are the characteristics of phosphate binders?

  • not for prevention of hyperphosphatemia

  • reduces phosphorus absorption & serum levels

  • forms insoluble complexes that are excreted in stool

  • must be taken with meals


61
New cards

What foods are high in phosphorous?

  • seeds

  • chocolate

  • fish/shellfish

  • nuts

  • pork/beef/veal

  • low fat dairy

  • tofu

  • beans/lentils

  • cheese

  • beer/carbonated drinks


62
New cards

What agents are phosphate binders?

  • aluminum-containing

  • calcium-containing

  • sevelamer/lanthanum


63
New cards

Which phosphate binder agent should be avoided & why?

aluminum-containing phosphate binders

  • aluminum toxicity


64
New cards

What dose of elemental calcium should not be exceeded?

1500mg/day

  • to prevent tissue calcification


65
New cards

With what measures are calcium-containing phosphate binders not recommended?

  • calcium >10.2 mg/dL

  • PTH <150 pg/mL


66
New cards

What agent is suggested for lowering serum phosphorus levels?

  • calcium-based phosphate binders are effective in lowering serum phosphorus levels

  • in adults with CKD G3a-5 receiving phosphate-lowering treatment, calcium-based phosphate should be restricted


67
New cards

What is the impact of CKD on vitamin D?

the ability to convert 25D → 1,25D is lost as kidney function declines

68
New cards

What are the effects of active vitamin D administration for CKD patients?

  • suppresses PTH → stimulation of calcium & phosphorus absorption in intestines

  • improves bone histology, increases BMD


69
New cards

After what parameter is reached should vitamin D be given in CKD?

after PO4 levels are controlled

  • vitamin D can worsen hyperphosphatemia because it increases absorption in intestines


70
New cards

What agents are the inactive form (precursor) of vitamin D (PO)?

  • ergocalciferol (D2)

  • cholecalciferol (D3)

  • calcifediol (D3)


71
New cards

What agents are activated vitamin D (PO or IV)?

  • calcitriol

  • paricalcitol

  • doxercalciferol


72
New cards

When should vitamin D (D2 or D3) be administered in CKD?

stages 3-5

  • serum levels of 25(OH)-vitamin D are low (<30 ng/dL)

  • severe & progressive hyperparathyroidism

  • calcium <9.5 mg/dL + phosphorous <4.6 mg/dL


73
New cards

What are dosage adjustments of inactive vitamin D based on?

PTH, calcium, & phosphorous levels

74
New cards

When should active vitamin D be considered in CKD?

if PTH remains elevated despite adequate 25(OH)D levels

  • stage 5 CKD


75
New cards

What is the efficacy of IV vs PO calcitriol?

  • iv is more effective

  • iv also has a high incidence of hypercalcemia


76
New cards

What is the MOA of calcimimetics?

attaches to calcium receptor in parathyroid gland & increases sensitivity of receptors to serum calcium concentration, reducing PTH

77
New cards

What is the place in therapy of calcimimetics?

  • useful in patients with high calcium/phosphate/PTH

  • CKD stage 5


78
New cards

What agents are calcimimetics?

  • cinacalcet HCl (sensipar)

  • etelcalcetide


79
New cards

What are the ADE of cinacalcet HCl?

hypocalcemia

80
New cards

What are the ADE of etelcalcetide?

hypocalcemia

  • longer half life than cinacalcet, more GI side affects

  • d/c cinacalcet HCl for at least 7 days prior to initiating etelcalcetide


81
New cards

When should serum calcium be monitored in stage 3?

every 6-12mo

82
New cards

When should serum calcium be monitored in stage 4?

every 3-6mo

83
New cards

When should serum calcium be monitored in stage 5?

every 1-3mo

84
New cards

When should serum phosphorus be monitored in stage 3?

every 6-12mo

85
New cards

When should serum phosphorus be monitored in stage 4?

every 3-6mo

86
New cards

When should serum phosphorus be monitored in stage 5?

every 1-3mo

87
New cards

When should PTH be monitored in stage 3?

baseline & CKD progression

88
New cards

When should PTH be monitored in stage 4?

every 6-12mo

89
New cards

When should PTH be monitored in stage 5?

every 3-6mo

90
New cards

When should 25(OH)D be monitored in CKD?

baseline & following therapeutic intervention

91
New cards

What agent should be used if ↑phos and avoided if ↓phos?

binders

92
New cards

What agent should be used if ↑PTH (↓Ca) & avoided if ↓PTH, ↑Ca, ↑phos?

calcitriol

93
New cards

What agent should be used if ↑PTH, ↑Ca, ↑phos & avoided if ↓Ca, ↓phos?

cinacalcet

94
New cards

What is the pathophysiology of sodium & water abnormalities in CKD?

  • reduced ability to concentrate/dilute water

  • significant sodium retention can occur

  • volume overload with pulmonary edema

  • HTN


95
New cards

What is the goal of therapy in sodium & water retention in CKD?

maintain sodium concentration (135-145 mEq/L) & euvolemic state

  • restrict dietary sodium & fluid intake


96
New cards

What agents are used in sodium & water abnormalities in CKD?

  • stage 1-3 → thiazide

  • stage 4-5 → loop


97
New cards

What is the pathophysiology of potassium abnormality in CKD?

kidney’s excrete 90-95% of dietary potassium load

  • advanced CKD → hyperkalemia


98
New cards

What are the goals of therapy in potassium retention in CKD?

  • prevent hyperkalemia

  • dietary restriction, limit meds that can increase potassium


99
New cards

What are treatment options for hyperkalemia in CKD?

  • sodium potassium exchange resins

    • kayexalate-sps

    • veltassa-patiromer

    • lokelma-szc

  • hemodialysis

  • acute management


100
New cards

What is the pathophysiology of metabolic acidosis in CKD?

serum bicarbonate concentrations less than 22 mmol/l → associated with increased risk of CKD progression & mortality